Characterizing antiviral mechanism of interleukin-32 and a circulating soluble isoform in viral infection

Cytokine

Volumn 58, Issue 1, 2012, Pages 79-86

  Bae, Suyoung ^a   Kang, Dongjun ^a   Hong, Jaewoo ^a   Chung, Byunghyun ^a   Choi, Jida ^a   Jhun, Hyunjhung ^a   Hong, Kwangwon ^a   Kim, Eunsom ^a   Jo, Seunghyun ^a   Lee, Siyoung ^a   Kim, Sung Han ^b   Kim, Soohyun ^a  

^a Konkuk University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Antiviral; Cytokine; Recombinant IL 32 ; THP 1 cell; Transferrin

Indexed keywords

ALPHA2 INTERFERON; GAMMA INTERFERON; INTERLEUKIN 32; INTERLEUKIN 6; INTERLEUKIN 8; ISOPROTEIN; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 32 GAMMA; RECOMBINANT PROTEIN; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL SIZE; CONTROLLED STUDY; EPITHELIUM CELL; FRACTIONATION; HUMAN; HUMAN CELL; INFLUENZA A (H1N1); LEUKOCYTE; MASS SPECTROMETRY; MONOCYTE; MULTINUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SUPERNATANT; T LYMPHOCYTE; TRANSGENIC MOUSE; VESICULAR STOMATITIS VIRUS;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; EPITHELIAL CELLS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTERLEUKIN-6; INTERLEUKINS; MICE; PROTEIN ISOFORMS; RECOMBINANT PROTEINS; TRANSFERRIN; VESICULAR STOMATITIS INDIANA VIRUS;

MUS MUSCULUS; MYCOBACTERIUM TUBERCULOSIS; VESICULAR STOMATITIS VIRUS;

EID: 84862785772     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.12.024     Document Type: Article

References (39)

1. Dahl C.A., Schall R.P., He H.L., Cairns J.S. Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol 1992, 148:597-603.
2. Kim S.H., Han S.Y., Azam T., Yoon D.Y., Dinarello C.A. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 2005, 22:131-142.
3. Choi J.D., Bae S.Y., Hong J.W., Azam T., Dinarello C.A., Her E., et al. Identification of the most active interleukin-32 isoform. Immunology 2009, 126:535-542.
4. Cagnard N., Letourneur F., Essabbani A., Devauchelle V., Mistou S., Rapinat A., et al. Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur Cytokine Netw 2005, 16:289-292.
5. Joosten L.A., Netea M.G., Kim S.H., Yoon D.Y., Oppers-Walgreen B., Radstake T.R., et al. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 2006, 103:3298-3303.
6. Mun S.H., Kim J.W., Nah S.S., Ko N.Y., Lee J.H., Kim J.D., et al. Tumor necrosis factor alpha-induced interleukin-32 is positively regulated via the Syk/protein kinase Cdelta/JNK pathway in rheumatoid synovial fibroblasts. Arthritis Rheum 2009, 60:678-685.
7. Kundu M., Basu J. IL-32: an emerging player in the immune response network against tuberculosis?. PLoS Med 2006, 3:e274.
8. Netea M.G., Azam T., Ferwerda G., Girardin S.E., Walsh M., Park J.S., et al. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 2005, 102:16309-16314.
9. Fantini M.C., Monteleone G., Macdonald T.T. New players in the cytokine orchestra of inflammatory bowel disease. Inflamm Bowel Dis 2007, 13:1419-1423.
10. Shioya M., Nishida A., Yagi Y., Ogawa A., Tsujikawa T., Kim-Mitsuyama S., et al. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 2007, 149:480-486.
11. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001, 1:135-145.
12. Kim K.H., Shim J.H., Seo E.H., Cho M.C., Kang J.W., Kim S.H., et al. Interleukin-32 monoclonal antibodies for immunohistochemistry, Western blotting, and ELISA. J Immunol Methods 2008, 333:38-50.
13. Nishida A., Andoh A., Inatomi O., Fujiyama Y. Interleukin-32 expression in the pancreas. J Biol Chem 2009, 284:17868-17876.
14. Seo E.H., Kang J., Kim K.H., Cho M.C., Lee S., Kim H.J., et al. Detection of expressed IL-32 in human stomach cancer using ELISA and immunostaining. J Microbiol Biotechnol 2008, 18:1606-1612.
15. Sorrentino C., Di Carlo E. Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. Am J Respir Crit Care Med 2009, 180:769-779.
16. Lee S., Kim S., Bae S., Choi J., Hong J., Ryoo S., et al. Interleukin-32 gamma specific monoclonal antibody and developing IL-32 specific ELISA. Hybridoma (Larchmt) 2010, 29:501-509.
17. Li W., Liu Y., Mukhtar M.M., Gong R., Pan Y., Rasool S.T., et al. Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLoS One 2008, 3:e1985.
18. Li W., Yang F., Liu Y., Gong R., Liu L., Feng Y., et al. Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection. Eur J Immunol 2009, 39:1019-1024.
19. Nold M.F., Nold-Petry C.A., Pott G.B., Zepp J.A., Saavedra M.T., Kim S.H., et al. Endogenous IL-32 controls cytokine and HIV-1 production. J Immunol 2008, 181:557-565.
20. Rasool S.T., Tang H., Wu J., Li W., Mukhtar M.M., Zhang J., et al. Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication. Immunol Lett 2008, 117:161-167.
21. Alsaleh G., Sparsa L., Chatelus E., Ehlinger M., Gottenberg J.E., Wachsmann D., et al. Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 2010, 12:R135.
22. Choi J., Bae S., Hong J., Ryoo S., Jhun H., Hong K., et al. Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis. Proc Natl Acad Sci USA 2010, 107:21082-21086.
23. Netea M.G., Azam T., Lewis E.C., Joosten L.A., Wang M., Langenberg D., et al. Mycobacterium tuberculosis induces interleukin-32 production through a caspase-1/IL-18/interferon-gamma-dependent mechanism. PLoS Med 2006, 3:e277.
24. Hasegawa H., Thomas H.J., Schooley K., Born T.L. Native IL-32 is released from intestinal epithelial cells via a non-classical secretory pathway as a membrane-associated protein. Cytokine 2010, 53:74-83.
25. Bai X., Kim S.H., Azam T., McGibney M.T., Huang H., Dinarello C.A., et al. IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages. J Immunol 2010, 184:3830-3840.
26. Kim S., Lee S., Her E., Bae S., Choi J., Hong J., et al. Proteinase 3-processed form of the recombinant IL-32 separate domain. BMB Rep 2008, 41:814-819.
27. Anderson B.F., Baker H.M., Norris G.E., Rice D.W., Baker E.N. Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8A resolution. J Mol Biol 1989, 209:711-734.
28. Jeffrey P.D., Bewley M.C., MacGillivray R.T., Mason A.B., Woodworth R.C., Baker E.N. Ligand-induced conformational change in transferrins: crystal structure of the open form of the N-terminal half-molecule of human transferrin. Biochemistry 1998, 37:13978-13986.
29. Khan J.A., Kumar P., Paramasivam M., Yadav R.S., Sahani M.S., Sharma S., et al. Camel lactoferrin, a transferrin-cum-lactoferrin: crystal structure of camel apolactoferrin at 2.6A resolution and structural basis of its dual role. J Mol Biol 2001, 309:751-761.
30. Kurokawa H., Mikami B., Hirose M. Crystal structure of diferric hen ovotransferrin at 2.4A resolution. J Mol Biol 1995, 254:196-207.
31. Moore S.A., Anderson B.F., Groom C.R., Haridas M., Baker E.N. Three-dimensional structure of diferric bovine lactoferrin at 2.8A resolution. J Mol Biol 1997, 274:222-236.
32. Wally J., Halbrooks P.J., Vonrhein C., Rould M.A., Everse S.J., Mason A.B., et al. The crystal structure of iron-free human serum transferrin provides insight into inter-lobe communication and receptor binding. J Biol Chem 2006, 281:24934-24944.
33. Kawabata H., Yang R., Hirama T., Vuong P.T., Kawano S., Gombart A.F., et al. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 1999, 274:20826-20832.
34. Lee A.W., Oates P.S., Trinder D. Effects of cell proliferation on the uptake of transferrin-bound iron by human hepatoma cells. Hepatology 2003, 38:967-977.
35. Pfeffer L.M., Mullersman J.E., Pfeffer S.R., Murti A., Shi W., Yang C.H. STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science 1997, 276:1418-14120.
36. Yang C.H., Shi W., Basu L., Murti A., Constantinescu S.N., Blatt L., et al. Direct association of STAT3 with the IFNAR-1 chain of the human type I interferon receptor. J Biol Chem 1996, 271:8057-8061.
37. Hasegawa K., Motsuchi W., Tanaka S., Dosako S. Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn J Med Sci Biol 1994, 47:73-85.
38. Yamauchi K., Tomita M., Giehl T.J., Ellison R.T. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 1993, 61:719-728.
39. Ikeda M., Sugiyama K., Tanaka T., Tanaka K., Sekihara H., Shimotohno K., et al. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Biochem Biophys Res Commun 1998, 245:549-553.